Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo (Q36749553)

From Wikidata
Jump to navigation Jump to search
scientific article published on 4 January 2013
edit
Language Label Description Also known as
English
Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo
scientific article published on 4 January 2013

    Statements

    Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo (English)
    Huan Meng
    Wilson X Mai
    Haiyuan Zhang
    Min Xue
    Sijie Lin
    Yang Zhao
    Zhaoxia Ji
    Jeffrey I Zink
    Andre E Nel
    4 January 2013
    994-1005

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit